These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1721353)

  • 1. The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression.
    Torre-Cisneros J; Mañez R; Kusne S; Alessiani M; Martin M; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3040-1. PubMed ID: 1721353
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M; Neumann U; Knoop M; Bechstein WO; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
    Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P
    Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984
    [No Abstract]   [Full Text] [Related]  

  • 6. Does initial graft function influence the outcome after liver transplantation?
    Mueller AR; Platz KP; Krause P; Neuhaus R; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
    [No Abstract]   [Full Text] [Related]  

  • 7. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
    Platz KP; Mueller AR; Zytowski M; Bechstein WO; Blumhardt G; Lobeck H; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
    [No Abstract]   [Full Text] [Related]  

  • 8. FK 506 used as rescue therapy for refractory liver allograft rejection.
    Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
    Fung J; Abu-Elmagd K; Jain A; Gordon R; Tzakis A; Todo S; Takaya S; Alessiani M; Demetris A; Bronster O
    Transplant Proc; 1991 Dec; 23(6):2977-83. PubMed ID: 1721333
    [No Abstract]   [Full Text] [Related]  

  • 10. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine Neoral in liver transplant recipients.
    Levy G; Rochon J; Freeman D; Wong PY; Banks L; Roach C; Engel K; Grant D
    Transplant Proc; 1994 Oct; 26(5):2949-52. PubMed ID: 7940930
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical results of quadruple drug immunosuppression in liver transplantation.
    Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S
    Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217
    [No Abstract]   [Full Text] [Related]  

  • 13. FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
    Knoop C; Antoine M; Vachiéry JL; Yernault JC; Estenne M
    Transplant Proc; 1994 Dec; 26(6):3240-1. PubMed ID: 7527957
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.
    U.S. Multicenter FK506 Liver Study Group
    N Engl J Med; 1994 Oct; 331(17):1110-5. PubMed ID: 7523946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
    Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
    Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal immunosuppressive clinical regimen in liver transplantation.
    Farges O; Samuel D; Bismuth H
    Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
    Millis JM; Woodle ES; Piper JB; Bruce DS; Newell KA; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
    Transplantation; 1996 May; 61(9):1365-9. PubMed ID: 8629298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
    Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G
    Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
    [No Abstract]   [Full Text] [Related]  

  • 19. FK 506 versus cyclosporine in pediatric liver transplantation.
    Tzakis AG; Reyes J; Todo S; Green M; Ohya T; Jain A; Abu-Elmagd K; Alessiani M; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3010-5. PubMed ID: 1721343
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection.
    Fabregat J; Fradera R; Figueras J; Rafecas A; Torras J; Martinez LaCasa J; Baliellas C; Casais L; Jaurrieta E
    Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.